[Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood; D003627:Data Interpretation, Statistical; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004100:Dihydroxycholecalciferols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D006706:Homeostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011446:Prospective Studies; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D012449:Safety; D012536:Scalp Dermatoses / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; D004655:Emulsions; D010919:Placebos; C023850:1 alpha,24-dihydroxyvitamin D3; D002118:Calcium
Behandlung der Kopfhaut-Psoriasis. Gute Wirksamkeit und Sicherheit durch Tacalcitol-Emulsion.